Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.071 | 0.7 |